30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Shearman Mark S

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -28% 8.2% 15.1%
Success rate 34% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Shearman Mark S's trades of Editas Medicine Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-02-15 2023-02-13
S Sale
26,429 +7.7%
98.67
US$728,341 		26,429 +7.7% 98.67 US$728,341
2022-06-16 2022-06-15
S Sale
16,089 -35.6%
207.09
US$4,236,082 		16,089 -35.6% 207.09 US$4,236,082